Bio-pharmaceutical company , XenoPort, Inc. (XNPT), on Wednesday reported fourth-quarter net income of $3.0 million or $0.07 per share, compared to a net loss of $16.9 million or $0.48 per share in the comparable quarter last year.
Total revenues for the latest fourth-quarter were $0.4 million, compared to $5.38 million a year ago.
On average, analysts polled by Thomson Reuters expected a loss of $0.41 per share and revenues of $1.02 million for the fourth quarter. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com